Value and significance of brain radiation therapy during first‐line <scp>EGFR‐TKI</scp> treatment in lung adenocarcinoma with <scp><i>EGFR</i></scp> sensitive mutation and synchronous brain metastasis: Appropriate timing and technique

Abstract

Upfront brain RT based on first-line EGFR-TKI might improve IC-PFS but not OS in EGFR-mutant lung adenocarcinoma patients, indicating potential survival benefit from brain SRS and early application of drugs with higher intracranial activity.